Pharmacokinetic and Pharmacodynamic Perspectives on the Clinical Drug Development of Panitumumab

Author： Yang Bing-Bing Lum Peggy Chen Alin Arends Rosalin Roskos Lorin Smith Brian Ruixo Juan José Pérez

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.49, Iss.11, 2010-11, pp. : 729-740

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib

By Takemoto Jody K.

Clinical Pharmacokinetics, Vol. 47, Iss. 11, 2008-01 ,pp. : 703-720

Adis International

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming Chow Andrew

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

Nanomedicine based on Nucleic Acids: Pharmacokinetic and Pharmacodynamic Perspectives

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 9, 2014-09 ,pp. : 829-838

Bentham Science Publishers

Access to resources Recommend Favorite

A Pharmacokinetic–Pharmacodynamic Model of Chemotherapy of Human Immunodeficiency Virus Infection that Relates Development of Drug Resistance to Treatment Intensity

By Jackson Robert C.

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 25, Iss. 6, 1997-12 ,pp. : 713-730

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Population Pharmacokinetic- Pharmacodynamic Analyses on the Drug Development Process: Experience at Parke-Davis

By Olson S.C. Bockbrader H. Boyd R.A. Cook J. Koup J.R. Lalonde R.L. Siedlik P.H. Powell J.R.

Clinical Pharmacokinetics, Vol. 38, Iss. 5, 2000-05 ,pp. : 449-459

Adis International

Access to resources Recommend Favorite